IL17A and chronic obstructive pulmonary disease: Dexamethasone significantly reduced IL-2, IL-10, IL-13, and IL-17 release from NS and COPD patients; this ranged between 57-94% for NS and 57-93% for COPD patients, with no differences between groups.